Patients be informed of risks in self-administration: CDSCO Panel tells Takeda Biopharm on Agalsidase Alfa Susmita Roy11 Nov 2024 12:30 PMNew Delhi: In line with the proposal presented by Takeda Biopharmaceuticals for an update in the package insert regarding home infusion for Agalsidase...
Lupin bags tentative USFDA nod for Migalastat Capsules Ruchika Sharma2 April 2024 7:00 AMMigalastat Capsules are indicated for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene...
Early initiation of ERT in Fabry disease can eliminate major organ damage and yield enhanced long-term benefits: Case Study Medha Baranwal27 Feb 2024 8:45 PMChina: A recent article published in BMC Nephrology reports a case study of enzyme replacement therapy for Fabry disease (FD) presenting with...
